Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors 

• V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investors Oncode Oncology Bridge Fund, Swanbridge and BOM • Flindr discovers and develops...

Citryll announces the appointment of Maarten Kraan as Chief Medical Officer

OSS, the Netherlands, 13-02-2024 — Citryll, a clinical-stage biotech company developing first-in-class therapeutics to treat immune-mediated inflammatory diseases, today announced the appointment of Maarten Kraan, M.D., Ph.D., as Chief Medical Officer. Dr. Kraan is a...

Citryll announces appointments of Eduardo Bravo as CEO and Tim Schenk as CBO

20230829_Citryll_New CEO_and_New CBO_FINAL

Sirius Medical announces major funding round to further accelerate sales growth and new product development

Sirius Pintuition® – Moving from Localization to Surgical Marker Navigation Eindhoven, Netherlands – 28 March 2023 – Sirius Medical, the leader in surgical marker navigation, today announced the successful closing of a Series B Round 12 M€. The funding will accelerate...

Curie Capital start nieuw seedfonds

Curie Capital start nieuw seedfonds.docx

Cleara Biotech Raises $2.5 Million in Seed Financing to Advance FOXO4- Therapeutics Pipeline for Treating Cancer and Chronic Diseases

Cleara_PressRelease_Sep222022...